Please use this identifier to cite or link to this item:
Title: Systematic evaluation of multiple qPCR platforms, NanoString and miRNA-Seq for microRNA biomarker discovery in human biofluids
Authors: Hong, Lewis Z.
Zhou, Lihan
Zou, Ruiyang
Khoo, Chin Meng 
Chew, Adeline Lai San
Chin, Chih-Liang
Shih, Shian-Jiun
Issue Date: 24-Feb-2021
Publisher: Nature Research
Citation: Hong, Lewis Z., Zhou, Lihan, Zou, Ruiyang, Khoo, Chin Meng, Chew, Adeline Lai San, Chin, Chih-Liang, Shih, Shian-Jiun (2021-02-24). Systematic evaluation of multiple qPCR platforms, NanoString and miRNA-Seq for microRNA biomarker discovery in human biofluids. Scientific Reports 11 (1) : 4435. ScholarBank@NUS Repository.
Rights: Attribution 4.0 International
Abstract: Aberrant miRNA expression has been associated with many diseases, and extracellular miRNAs that circulate in the bloodstream are remarkably stable. Recently, there has been growing interest in identifying cell-free circulating miRNAs that can serve as non-invasive biomarkers for early detection of disease or selection of treatment options. However, quantifying miRNA levels in biofluids is technically challenging due to their low abundance. Using reference samples, we performed a cross-platform evaluation in which miRNA profiling was performed on four different qPCR platforms (MiRXES, Qiagen, Applied Biosystems, Exiqon), nCounter technology (NanoString), and miRNA-Seq. Overall, our results suggest that using miRNA-Seq for discovery and targeted qPCR for validation is a rational strategy for miRNA biomarker development in clinical samples that involve limited amounts of biofluids. © 2021, The Author(s).
Source Title: Scientific Reports
ISSN: 2045-2322
DOI: 10.1038/s41598-021-83365-z
Rights: Attribution 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1038_s41598-021-83365-z.pdf1.14 MBAdobe PDF




checked on Mar 23, 2023

Page view(s)

checked on Mar 16, 2023

Google ScholarTM



This item is licensed under a Creative Commons License Creative Commons